| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_26db05f349a12e10706b1e5ea02c860a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44bc6bcadb85e68f79c200143e6f1430 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-141 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
| filingDate |
2017-09-19^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-07-29^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fd605779970b2dcab6e869cce07f236
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dabf94292605f6a77ffc950e18bcf2c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95c80ab509cd2d32ea2c621063ec564c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eda8bb97aee79a9f492d38a2523bb53a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f600b32970656c1677806dac2097fcba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19af9f03b33963a0273e45a6618aabee |
| publicationDate |
2021-07-29^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2017328728-B2 |
| titleOfInvention |
Modulation of microRNAs against myotonic dystrophy type 1 and antagonists of microRNAs therefor |
| abstract |
Modulation of microRNAs against myotonic dystrophy type 1 and antagonists of microRNAs therefor. The invention provides the use of inhibitors of microRNAs repressors of |
| priorityDate |
2016-09-19^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |